Dockets

Federal rulemakings, soonest-closing first — each gathers its documents and comments.

NonrulemakingFAA

Knockout Mosquito Systems LLC - Exemption/Rulemaking

3
documents
9
comments
Last activity Jun 23, 2026View docket →
NonrulemakingFDA

Request for Comments on the Science and Technology Report; Establishment of Docket; Request for Comments

1
document
3
comments
Last activity Jun 23, 2026View docket →
NonrulemakingFDA

Providing Comments on CDER Level 2 Guidances

6
documents
1
comments
Last activity Jun 23, 2026View docket →
RulemakingFWS

Endangered and Threatened Wildlife and Plants; 90-Day Finding for Three Petitions To List the Yellowstone Bison

1
document
1.2K
comments
Last activity Jun 23, 2026View docket →
NonrulemakingFDA

Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research; Draft Guidance for Industry; Availability

1
document
7
comments
Last activity Jun 22, 2026View docket →
NonrulemakingFDA

Requests that the FDA Admit "Waste Parity" Status: Formally acknowledge that the active estrogenic metabolites used in approved conjugated equine estrogen (CEE) pharmaceuticals (such as Premarin) are molecularly identical to the raw equine metabolites the Agency classifies as prohibited "filth" under Section 402(a)(3) of the FD&C Act

2
documents
3
comments
Last activity Jun 21, 2026View docket →
NonrulemakingFDA

Requests that the FDA evaluate and assume jurisdiction over GonaCon-Equine and ZonaStat-H as New Animal Drugs.

29
documents
13
comments
Last activity Jun 21, 2026View docket →
NonrulemakingFDA

Requests that the FDA revise existing regulations and policies to require drug and dietary supplement manufacturers to clearly label whether ingredients used in their products are animal derived or contain animal byproducts.

1
document
1.6K
comments
Last activity Jun 20, 2026View docket →
NonrulemakingFDA

Request that the FDA take the administrative action to implement minimum RF safety national requirements for MRI devices to increase end-user understanding of the physical locations of RF risks (to better understand and manage those risks) and / or to eliminate the risk of near-field RF burns for MRI patients

2
documents
16
comments
Last activity Jun 19, 2026View docket →
NonrulemakingFDA

Request that the FDA publicly release documentation sufficient to establish that the aluminum content in Adacel, Boostrix, Engerix-B, Havrix, Infanrix, Infanrix hexa, Kinrix, Pediarix, Pedvax-HIB, Pentacel, Prevnar-13, Synflorix, and Vaqtais is consistent with amount provided in its labeling and pause distribution of each Subject Vaccine

1
document
4
comments
Last activity Jun 17, 2026View docket →
NonrulemakingFAA

Delta Air Lines, Inc. - Exemption/Rulemaking

3
documents
1
comments
Last activity Jun 16, 2026View docket →
NonrulemakingFDA

The Declaration of Allulose and Calories from Allulose on Nutrition and Supplement Facts Labels: Draft Guidance for Industry; Availability

1
document
5
comments
Last activity Jun 15, 2026View docket →